ARCHIVES

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants

February 23, 1996

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005

NCI, Litton Open Talks On Frederick Contract

February 6, 1976

DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio

January 1, 1988

Cancer Letter Skips Next Two Weeks

September 2, 1988